Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines

被引:12
|
作者
Meesungnoen, J
Jay-Gerin, JP
Mankhetkorn, S [1 ]
机构
[1] Burapha Univ, Fac Sci, Lab Phys Chem Mol & Cellular Biol, Chonburi 20131, Thailand
[2] Univ Sherbrooke, Fac Med, Dept Med Nucl & Radiobiol, Sherbrooke, PQ J1H 5N4, Canada
关键词
multidrug resistance; P-glycoprotein; pirarubicin; acidic organelles; MDR1 mRNA levels; fluorescence spectroscopy; kinetic parameters;
D O I
10.1139/Y02-132
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this work, we sought to investigate the relation existing between MDR1 mRNA levels, the resistance factor (RF), and the efficiency of efflux of pirarubicin (THP) mediated by P-glycoprotein (P-gp) in multidrug-resistant (MDR) K562 sublines. The MDR K562 sublines were selected from K562/adr cells by exposure to different adriamycin concentrations: 300 nM (K562/300), 1000 nM (K562/1000), and 10 000 nM (K562/10000), yielding RF values of 23.2, 26.5, and 39.6, respectively. The analysis of the P-gp encoding MDR1 gene overexpression by reverse transcriptase - polymerase chain reaction provided evidence of increased MDR1 mRNA levels when the adriamycin concentration used for the MDR cell selection increased. We used spectrofluorometric methods to determine the kinetics of the uptake and P-gp-mediated efflux of THP in the different selected MDR K562 sublines. Our data showed that (i) the maximal rate of P-gp-mediated efflux of THP, V-max, increased with increasing RF; (ii) the observed Michaelis constant, K-m, had the same value for all selected sublines, thus leading to an overall increase in the ratio V-max/K-m (5.1 x 10(-3), 6.2 x 10(-3), 6.8 x 10(-3), and 9.3 x 10(-3) s(-1) for K562/adr, K562/300, K562/1000, and K562/10000 cells, respectively), and (iii) the determination of the Hill coefficient (n(H)) gave values close to 2, which suggested a positive cooperative transport of THP with the expelling of two molecules of THP per turnover of P-gp. This study demonstrated that, in the K562/adr sublines used in our experiments, P-gp played a major role in conferring the MDR phenotype. Moreover, under our experimental conditions, intracellular acidic organelles were shown to contribute to decreased drug-target interaction and, thereby, decreased cytotoxicity. The variation of the concentrations of THP accumulated in the acidic organelles as a function of the total THP concentration added to the cells was the same, within the limits of experimental errors, whatever the degree of resistance of the studied MDR K562 sublines. Finally, this study suggested that, in the selected MDR K562 sublines, the K+/H+ antiporter exchanger could be activated by the pirarubicin transport, leading to a probable acidification of intracellular pH. The P-gp-mediated efflux of THP and an accumulation of THP in acidic organelles confer an advantage for MDR cells in surviving prolonged exposure to cytotoxic agents and giving rise to high degrees of resistance.
引用
收藏
页码:1054 / 1063
页数:10
相关论文
共 37 条
  • [21] Synthesis of New Steroidal Inhibitors of P-Glycoprotein-Mediated Multidrug Resistance and Biological Evaluation on K562/R7 Erythroleukemia Cells
    de Ravel, Marc Rolland
    Alameh, Ghina
    Melikian, Maxime
    Mahiout, Zahia
    Emptoz-Bonneton, Agnes
    Matera, Eva-Laure
    Lomberget, Thierry
    Barret, Roland
    Rocheblave, Luc
    Walchshofer, Nadia
    Beltran, Sonia
    El Jawad, Lucienne
    Mappus, Elisabeth
    Grenot, Catherine
    Pugeat, Michel
    Dumontet, Charles
    Le Borgne, Marc
    Cuilleron, Claude Yves
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (04) : 1832 - 1845
  • [22] CJX2, an amlodipine derivative, reverses p-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
    Ji, BS
    He, L
    Liu, GQ
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (04) : 278 - 285
  • [23] CJZ3, a lomerizine derivative, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells
    Ji, Bian-Sheng
    He, Ling
    Liu, Guo-Qing
    DRUG DEVELOPMENT RESEARCH, 2006, 67 (11) : 862 - 869
  • [24] Detection of P-glycoprotein-mediated multidrug resistance against anthelmintics in Haemonchus contortus using anti-human mdr1 monoclonal antibodies
    D. Kerboeuf
    F. Guégnard
    Y. Le Vern
    Parasitology Research, 2003, 91 : 79 - 85
  • [25] Detection of P-glycoprotein-mediated multidrug resistance against anthelmintics in Haemonchus contortus using anti-human mdr1 monoclonal antibodies
    Kerboeuf, D
    Guégnard, F
    Le Vern, Y
    PARASITOLOGY RESEARCH, 2003, 91 (01) : 79 - 85
  • [26] Overcoming of P-glycoprotein-mediated multidrug resistance in K562/A02 cells using riccardin F and pakyonol, bisbibenzyl derivatives from liverworts
    Ji, Mei
    Shi, Yanqiu
    Lou, Hongxiang
    BIOSCIENCE TRENDS, 2011, 5 (05) : 192 - 197
  • [27] INHIBITION BY ERYTHROID-DIFFERENTIATION FACTOR (ACTIVIN-A) OF P-GLYCOPROTEIN EXPRESSION IN MULTIDRUG-RESISTANT HUMAN K562 ERYTHROLEUKEMIA-CELLS
    OKABEKADO, J
    HAYASHI, M
    HONMA, Y
    HOZUMI, M
    TSURUO, T
    CANCER RESEARCH, 1991, 51 (10) : 2582 - 2586
  • [28] Synergistic effects of verapamil and anti-mdr1 ribozyme on reversion of multidrug resistance in the P-glycoprotein-positive K562 cell line
    Gong, Y
    Han, W
    Liu, J
    Chen, F
    Han, J
    Jin, Y
    Yong, RO
    LEUKEMIA, 2001, 15 (04) : 696 - 697
  • [29] Synergistic effects of verapamil and anti-mdr1 ribozyme on reversion of multidrug resistance in the P-glycoprotein-positive K562 cell line
    Y Gong
    W Han
    J Liu
    F Chen
    J Han
    Y Jin
    R Ou Yong
    Leukemia, 2001, 15 : 696 - 697
  • [30] AN ALTERED PATTERN OF CROSS-RESISTANCE IN MULTIDRUG-RESISTANT HUMAN-CELLS IS DETERMINED BY SPONTANEOUS MUTATIONS IN THE MDR1 (P-GLYCOPROTEIN) GENE
    CHOI, K
    CHEN, CJ
    KRIEGLER, M
    RONINSON, IB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 294 - 294